Thought Leadership
Search results
Article | March 07, 2014
Read more
Drug Labeling Games: Skinny Labels Getting an FDA Assist
Pharmaceutical Compliance Monitor
Blog | February 28, 2014
Fed. Cir. Confirms De Novo Review of Claim Construction
Fish & Richardson
Read more
Blog | February 21, 2014
No foreseeability exception to doctrine of equivalents
Fish & Richardson
Read more
Blog | February 20, 2014
Inurement for 102(g)(2) Does Not Require the Inventor to Expressly Direct Another to Reduce His Invention to Practice
Fish & Richardson
Read more
Blog | January 27, 2014
NDGA rejects two-supplier market theory for lost profits
Fish & Richardson
Read more
Blog | January 15, 2014
EDTX allows cost savings approach for royalties, based on cost of entire location network
Fish & Richardson
Read more
Blog | January 13, 2014
SDNY grants SJ of no pre-notice damages where plaintiff failed to plead marking
Fish & Richardson
Read more
Blog | December 24, 2013
SDNY comments on EMVR's application in pharma context
Fish & Richardson
Read more
Blog | December 23, 2013
DUtah Uses Infringer's Profits to Compute Royalty; Comments on Obligation to Award Reasonable Royalty
Fish & Richardson
Read more
Article | November 22, 2013
Read more
Hatch-Waxman Developments: Artificial Infringement by Artificial Drugs
Pharmaceutical Compliance Monitor